Norway Orthobiologics Market Size & Outlook, 2023-2030
Norway orthobiologics market, 2018-2030 (US$M)
Related Markets
Norway orthobiologics market highlights
- The Norway orthobiologics market generated a revenue of USD 28.8 million in 2023 and is expected to reach USD 39.3 million by 2030.
- The Norway market is expected to grow at a CAGR of 4.5% from 2024 to 2030.
- In terms of segment, viscosupplementation was the largest revenue generating product in 2023.
- Stem Cell Therapy is the most lucrative product segment registering the fastest growth during the forecast period.
Orthobiologics market data book summary
| Market revenue in 2023 | USD 28.8 million |
| Market revenue in 2030 | USD 39.3 million |
| Growth rate | 4.5% (CAGR from 2023 to 2030) |
| Largest segment | Viscosupplementation |
| Fastest growing segment | Stem Cell Therapy |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Demineralized Bone Matrix(DBM), Allograft, Bone Morphogenetic Protein (BMP), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy |
| Key market players worldwide | Medtronic PLC, DePuy Synthes, Zimmer Biomet Holdings Inc, Stryker Corp, Bioventus Inc Class A, Anika Therapeutics Inc, Orthofix Medical Inc, Globus Medical Inc Class A, Bone Biologics Corp, Arthrex |
Other key industry trends
- In terms of revenue, Norway accounted for 0.5% of the global orthobiologics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany orthobiologics market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 275.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Orthobiologics Market Scope
Orthobiologics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway orthobiologics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthobiologics market will help companies and investors design strategic landscapes.
Viscosupplementation was the largest segment with a revenue share of 42.36% in 2023. Horizon Databook has segmented the Norway orthobiologics market based on demineralized bone matrix(dbm), allograft, bone morphogenetic protein (bmp), viscosupplementation, synthetic bone substitutes, stem cell therapy covering the revenue growth of each sub-segment from 2018 to 2030.
- Norway Orthobiologics Product Outlook (Revenue, USD Million, 2018-2030)
- Demineralized Bone Matrix(DBM)
- Allograft
- Bone Morphogenetic Protein (BMP)
- Viscosupplementation
- Synthetic Bone Substitutes
- Stem Cell Therapy
- Norway Orthobiologics Application Outlook (Revenue, USD Million, 2018-2030)
- Spinal Surgery
- Trauma Repair
- Reconstructive Surgery
- Norway Orthobiologics End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Clinics
Reasons to subscribe to Norway orthobiologics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway orthobiologics market databook
-
Our clientele includes a mix of orthobiologics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway orthobiologics market , including forecasts for subscribers. This country databook contains high-level insights into Norway orthobiologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway orthobiologics market size, by product, 2018-2030 (US$M)
Norway Orthobiologics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
